Private company
DYNATRONICS CORP
Leading medical device company1
In its 2025 annual report the company says: “The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others.”4 It is headquartered in Salt Lake City, Utah.1
Last updated Oct 21, 2026.
Overview
- IndustrySurgical & Medical Instruments & Apparatus1
- HeadquartersSalt Lake City, Utah1
- Incorporated inUT3
- Business address7030 Park Centre Drive, Bldg D, Salt Lake City, Ut 841213
- Filer categoryNon-accelerated filer, Smaller reporting company3
See how the biggest companies compare on our leaderboards
Dynatronics Corporation is a leading medical device company committed to providing high-quality products designed to accelerate optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue71¢$21.4M
- Selling, general and admin28¢$8.5M
- Interest1¢$409.9K
- Income tax0¢$12.2K
Out of $27.4M in revenue.2 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending10¢$30.4K
- Kept or used elsewhere90¢$270.1K
Out of $300.6K of cash from operations.2
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $64.4M5 | $62.6M6 | $53.4M7 | $47.8M8 | $44.3M9 | $40.6M10 | $32.5M2 | $27.4M2 |
| Cost of revenue | $44.0M5 | $43.4M6 | $38.3M7 | $34.9M8 | $33.7M9 | $30.5M10 | $24.9M2 | $21.4M2 |
| Gross profit | $20.4M5 | $19.2M6 | $15.1M7 | $12.9M8 | $10.7M9 | $10.2M10 | $7.6M2 | $6.0M2 |
| Research and development | $1.2M13 | $54.0K6 | $95.0K7 | $10.0K7 | ||||
| Selling, general and admin | $21.7M5 | $20.0M6 | $18.1M7 | $16.6M8 | $15.4M9 | $15.0M10 | $9.9M2 | $8.5M2 |
| Operating income | -$1.3M5 | -$796.1K6 | -$3.0M7 | -$3.8M8 | -$4.8M9 | -$4.9M10 | -$2.3M2 | -$2.5M2 |
| Interest | -$428.5K5 | $512.2K6 | $435.6K7 | $215.6K8 | $148.0K9 | $118.3K10 | $418.0K2 | $409.9K2 |
| Income before tax | -$4.0M9 | -$5.0M10 | -$2.7M2 | -$10.9M2 | ||||
| Income tax | $70.3K5 | $5.5K6 | -$10.1K7 | $10.0K8 | $09 | $010 | $02 | $12.2K2 |
| Net income | -$1.6M5 | -$921.7K6 | -$3.4M7 | $2.0M8 | -$4.0M9 | -$5.0M10 | -$2.7M2 | -$10.9M2 |
| Earnings per share | -$1.329 | -$1.4610 | -$1.002 | -$1.432 | ||||
| Earnings per share (diluted) | -$1.329 | -$1.4610 | -$1.002 | -$1.432 | ||||
| Shares (weighted, basic) | 3.6M shares9 | 3.9M shares10 | 3.4M shares2 | 8.1M shares2 | ||||
| Shares (weighted, diluted) | 3.6M shares9 | 3.9M shares10 | 3.4M shares2 | 8.1M shares2 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash | $1.6M5 | $155.5K6 | $2.2M7 | $6.1M8 | $550.1K9 | $398.8K10 | $483.9K2 | $326.3K2 |
| Receivables | $5.4M9 | $3.7M10 | $3.4M2 | $2.8M2 | ||||
| Inventory | $12.1M9 | $7.4M10 | $5.6M2 | $5.1M2 | ||||
| Current assets | $21.4M5 | $19.9M6 | $16.1M7 | $20.9M8 | $19.2M9 | $12.4M10 | $10.6M2 | $9.0M2 |
| Property, plant and equipment | $2.9M9 | $2.4M10 | $2.0M2 | $1.5M2 | ||||
| Goodwill | $7.1M9 | $7.1M10 | $7.1M2 | $02 | ||||
| Intangible assets | $4.2M9 | $3.6M10 | $3.0M2 | $1.4M2 | ||||
| Total assets | $42.1M5 | $39.6M6 | $37.6M7 | $39.1M8 | $35.4M9 | $30.1M10 | $25.9M2 | $15.4M2 |
| Accounts payable | $6.2M9 | $4.5M10 | $2.7M2 | $3.4M2 | ||||
| Short-term debt | $5.4K9 | $09 | ||||||
| Current liabilities | $14.6M5 | $14.3M6 | $7.7M7 | $8.5M8 | $9.9M9 | $7.9M10 | $7.7M2 | $8.2M2 |
| Long-term debt | $303.3K5 | $129.4K6 | $3.5M7 | $5.4K8 | $08 | |||
| Total liabilities | $20.7M5 | $18.9M6 | $17.7M7 | $13.6M8 | $13.7M9 | $13.2M10 | $11.8M2 | $12.2M2 |
| Retained earnings | -$19.8M9 | -$25.5M10 | -$28.9M2 | -$40.5M2 | ||||
| Shareholders’ equity | $21.4M6 | $20.8M7 | $19.9M8 | $25.5M9 | $21.7M10 | $16.9M2 | $14.2M2 | $3.3M2 |
| Shares outstanding | 8.2M shares13 | 8.7M shares5 | 14.1M shares6 | 17.8M shares7 | 18.6M shares8 | 4.3M shares9 | 5.9M shares10 | 16.0M shares2 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | $761.8K5 | $325.7K6 | $3.1M7 | $383.0K8 | -$4.9M9 | $371.1K10 | -$1.6M2 | $300.6K2 |
| Depreciation and amortization | $733.6K9 | $726.4K10 | $685.4K2 | $487.0K2 | ||||
| Stock-based compensation | $178.1K9 | $131.3K10 | $1.6K2 | $3.4K2 | ||||
| Capital spending | $242.9K5 | $224.1K6 | $292.4K7 | $146.9K8 | $317.8K9 | $186.9K10 | $243.3K2 | $30.4K2 |
| Free cash flow | $518.9K | $101.6K | $2.8M | $236.1K | -$5.2M | $184.3K | -$1.9M | $270.1K |
| Cash from investing | -$317.8K9 | -$186.9K10 | -$243.3K2 | -$30.4K2 | ||||
| Cash from financing | -$350.1K9 | -$332.7K10 | $1.8M2 | -$427.7K2 |
Corporate structure
DYNATRONICS CORP sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of DYNATRONICS CORP
- ARMISTICE CAPITAL, LLC Filed SCHEDULE 13G/A on DYNATRONICS CORP, latest Feb 17, 2026 (4 filings since Feb 15, 2022)
- RENAISSANCE TECHNOLOGIES LLC Filed SC 13G/A on DYNATRONICS CORP, latest Feb 13, 2023 (2 filings since Feb 11, 2022)
- Nancy Cronin Filed SC 13G/A on DYNATRONICS CORP, latest Jan 14, 2022
- DYNATRONICS CORP Salt Lake City, Utah
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What DYNATRONICS CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $6.8M2 Jun 30, 2025 | $7.4M2 Jun 30, 2024 | −7.7% |
| Accumulated depreciation | $5.3M2 Jun 30, 2025 | $5.4M2 Jun 30, 2024 | −2.2% |
| Property and equipment, net | $1.5M2 Jun 30, 2025 | $2.0M2 Jun 30, 2024 | −23.1% |
| Operating-lease assets (leased space) | $3.2M2 Jun 30, 2025 | $2.8M2 Jun 30, 2024 | +12.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $326.3K2 Jun 30, 2025 | $483.9K2 Jun 30, 2024 | −32.6% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $02 Jun 30, 2025 | $7.1M2 Jun 30, 2024 | −100.0% |
| Intangible assets, net (excluding goodwill) | $1.4M2 Jun 30, 2025 | $3.0M2 Jun 30, 2024 | −52.3% |
| Indefinite-lived intangibles (excluding goodwill) | $4.5M2 Jun 30, 2025 | $7.7M2 Jun 30, 2024 | −41.4% |
| Accumulated amortization | $3.1M2 Jun 30, 2025 | $4.7M2 Jun 30, 2024 | −34.5% |
| Finite-lived intangibles, net | $873.4K2 Jun 30, 2025 | $1.9M10 Jun 30, 2024 | −54.4% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $5.1M2 Jun 30, 2025 | $5.6M2 Jun 30, 2024 | −9.3% |
| Raw materials | $3.3M2 Jun 30, 2025 | $3.6M2 Jun 30, 2024 | −9.3% |
| Work in process | $351.5K2 Jun 30, 2025 | $315.1K2 Jun 30, 2024 | +11.6% |
| Finished goods | $2.0M2 Jun 30, 2025 | $2.3M2 Jun 30, 2024 | −11.3% |
Properties, in its own words
We lease a 57,000 square-foot manufacturing, warehouse, and office facility in Eagan, Minnesota, which houses our corporate headquarters and principal executive offices. Lease payments are $40,000 per month. The original term of the lease is for thirty nine months, commencing in April 2025. The lease is subject to 4% increases each subsequent year. The lease also includes a renewal option for an additional 36 months at Market Rate. We believe that the terms of the agreement are commercially reasonable for the market in which the facility is located.
We lease a 60,000 square-foot manufacturing and office facility in Northvale, New Jersey to house our Hausmann Enterprises, LLC operations. The initial two-year term of this lease commenced in April 2017, with monthly lease payments of $30,000 for the first year and 2% increases in each subsequent year. The lease provides for two options to extend the term of the lease for two years per extension term, subject to annual 2% per year increases in base rent, and a third extension option at the end of the second option term for an additional five years at fair market value. We have exercised options to extend the term of the lease through March 2028, with monthly lease payments of $60,000 for the first year, 2% increases each subsequent year, and monthly solar payments that total approximately $9,000 per year starting July 2023. The landlord is a stockholder and the previous owner of the assets and operations acquired in 2017. The lease was negotiated at arms' length as part of the Hausmann acquisition. We believe that the terms of the agreement are commercially reasonable for the market in which the facility is located.
The rest of Item 2
We lease a 36,000 square-foot manufacturing, warehouse, and office facility in Cottonwood Heights, Utah. We sold the building in August 2014, and now lease it back from the purchaser. The monthly lease payment is approximately $32,000 and the lease terminates in 2029. We account for the lease-back agreement as a finance lease which results in depreciation and implied interest expense each period, offset by an amortized gain on the sale of the property. Overall the net monthly occupancy cost of this lease is $40,000.
We believe the facilities described above are adequate for our current needs and that they will accommodate our presently expected growth and operating needs. As our business continues to grow, additional facilities or the expansion of existing facilities may be required.
We also own computer equipment, and equipment used in the manufacture and assembly of our products. The nature of this equipment is not specialized and replacements may be readily obtained from any of a number of suppliers.
Item 2 of the 10-K filed Oct 14, 2025.4
Leadership
Who has led DYNATRONICS CORP, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerJohn Anthony Krier Jul 21, 2020 to Jul 13, 202314
- Chief executive officerJako Christopher Richard Von Jun 27, 2018 to Jul 3, 201915
- Chief executive officerKelvyn H. Cullimore Jr. Jan 4, 2007 to Sep 17, 201916
- ChairKelvyn H. Cullimore Jr. Jan 4, 2007 to Nov 24, 201516
- PresidentKelvyn H. Cullimore Jr. Jan 4, 2007 to Dec 30, 201416
- Chief financial officerJohn Anthony Krier Oct 4, 2023 to Oct 4, 202317
- Chief financial officerGabriel Ellwein Nov 9, 2023 to Nov 9, 202318
- Chief financial officerNorman Roegner Iii. Sep 1, 2021 to Jul 22, 202219
- Chief financial officerDavid Alma Wirthlin Apr 20, 2017 to Jan 7, 202020
- Chief financial officerTerry M. Atkinson Jul 3, 2007 to Jul 3, 200721
- Chief operating officerRyan Edward Staats May 12, 2025 to now22
Board members and other officers (26)
- Corporate ControllerSkyler N. Black Jul 21, 2020 to Jul 21, 202023
- VP, OperationsCynthia L. McHenry Jul 25, 2018 to Jul 25, 201824
- Chief Information OfficerDaryl Connell Jul 25, 2018 to Jul 25, 201825
- Vice PresidentJames Norman Ogilvie Apr 20, 2017 to Jan 7, 202026
- Sr. VP of SalesThomas J. Gephart Mar 16, 2016 to Jan 4, 201827
- VP of Information TechnologyBryan David Alsop Jul 22, 2011 to Jul 22, 201128
- VP Product and R&DDouglas G. Sampson Oct 1, 2009 to Oct 1, 200929
- Executive VPLarry K. Beardall Apr 10, 2008 to Nov 24, 201530
- Secretary/TreasurerRobert J. Cardon Jan 11, 2007 to Jul 11, 201631
- VP R&DRonald J. Hatch Jul 3, 2007 to Jul 3, 200732
- Board memberAndrew Hulett Jan 17, 2024 to now33
- Board memberJohn Anthony Krier Jul 12, 2021 to Jul 13, 202334
- Board memberJako Christopher Richard Von Jun 27, 2018 to Jul 3, 201915
- Board memberScott Klosterman Jan 14, 2016 to Jan 4, 202435
- Board memberRichard James Linder Mar 26, 2015 to Mar 26, 201536
- Board memberBrian Larkin Jul 10, 2015 to now37
- Board memberDavid B. Holtz Dec 30, 2015 to now38
- Board memberR. Scott Ward Jun 12, 2013 to now39
- Board memberKelvyn H. Cullimore Jr. Apr 10, 2008 to Sep 17, 201940
- Board memberLarry K. Beardall Apr 10, 2008 to Nov 24, 201530
- Board memberMark Crockett Jul 22, 2008 to Jul 22, 200841
- Board memberE. Keith Hansen Mar 29, 2006 to Apr 10, 200842
- Board memberHoward L. Edwards Mar 29, 2006 to Jul 21, 201543
- Board memberJoseph H. Barton Mar 29, 2006 to Jan 29, 201444
- Board memberVal John Christensen Mar 29, 2006 to Jul 8, 201345
- General counselJennifer Bennett Bennett Keeler Dec 30, 2019 to Dec 30, 201946
Timeline
- Jan 12, 20268-K Bankruptcy or receivership; Debt or obligation accelerated; Executive or director change47
- Dec 17, 20258-K Shareholder vote48
- May 9, 20258-K Executive or director change49
- Apr 18, 20258-K Executive or director change50
- Apr 4, 20258-K Entered a material agreement51
- Dec 9, 20248-K Shareholder vote52
- Sep 24, 20248-K Executive or director change53
- Jun 28, 20248-K Listing notice or transfer; Regulation FD disclosure54
- May 16, 20248-K Results of operations55
- Apr 29, 20248-K Listing notice or transfer56
- Mar 20, 20248-K Executive or director change57
- Feb 8, 20248-K Results of operations58
- Jul 21, 2020New chief executive John Anthony Krier becomes CEO14
- Jun 27, 2018New chief executive Jako Christopher Richard Von becomes CEO15
- Jan 4, 2007New chief executive Kelvyn H. Cullimore Jr. becomes CEO16
Calendar
When it reported results
- May 16, 2024Reported quarterly or annual results55
- Feb 8, 2024Reported quarterly or annual results58
- Nov 9, 2023Reported quarterly or annual results59
- Sep 28, 2023Reported quarterly or annual results60
- May 11, 2023Reported quarterly or annual results61
- Feb 9, 2023Reported quarterly or annual results62
- Nov 10, 2022Reported quarterly or annual results63
- Sep 22, 2022Reported quarterly or annual results64
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
210 filings to the SEC since October 2021: 4 annual reports, 13 quarterly reports, 44 major events, 126 insider forms, 7 large holders, 16 other. The latest 20:
- Feb 17, 2026SCHEDULE 13G/A EDGAR
- Jan 12, 20268-K EDGAR
- Dec 17, 20258-K EDGAR
- Nov 19, 202510-Q EDGAR
- Nov 17, 2025NT 10-Q EDGAR
- Oct 30, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 30, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 30, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 30, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 28, 2025ARS EDGAR
- Oct 28, 2025DEFA14A EDGAR
- Oct 28, 2025DEF 14A EDGAR
- Oct 23, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 15, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 15, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 15, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 15, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 14, 202510-K EDGAR
- Oct 3, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Oct 3, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
The 210 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
13 open-market trades by officers, directors and large owners since October 2021: 13 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 4, 2022 | Ward R ScottDirector | Buy | 5,000 | Form 4 | ||
| Jan 4, 2022 | Provco Ventures 1 LP10% owner | Buy | 37,552 | Form 4 | ||
| Jan 4, 2022 | LARKIN BRIANDirector | Buy | 3,734 | Form 4 | ||
| Jan 4, 2022 | KLOSTERMAN SCOTTDirector | Buy | 5,000 | Form 4 | ||
| Jan 4, 2022 | HOLTZ DAVID BDirector | Buy | 5,000 | Form 4 | ||
| Jan 4, 2022 | ESSIG STUART10% owner | Buy | 80,146 | Form 4 | ||
| Jan 4, 2022 | ENRIGHT ERIN S.Director | Buy | 80,146 | Form 4 | ||
| Jan 4, 2022 | Baker Brian D.President & CEO, CFO | Buy | 8,734 | Form 4 | ||
| Oct 4, 2021 | Provco Ventures 1 LP10% owner | Buy | 26,155 | Form 4 | ||
| Oct 4, 2021 | LARKIN BRIANDirector | Buy | 2,601 | Form 4 | ||
| Oct 4, 2021 | ESSIG STUART10% owner | Buy | 52,338 | Form 4 | ||
| Oct 4, 2021 | ENRIGHT ERIN S.Director | Buy | 52,338 | Form 4 | ||
| Oct 4, 2021 | Baker Brian D.President & CEO, CFO | Buy | 3,671 | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- ARMISTICE CAPITAL, LLCSCHEDULE 13G/A, 4 filings Feb 15, 2022 to Feb 17, 202665
- RENAISSANCE TECHNOLOGIES LLCSC 13G/A, 2 filings Feb 11, 2022 to Feb 13, 202366
- Nancy CroninSC 13G/A, 1 filing Jan 14, 202267
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Brian D. Baker | 59 | $200.1K | $213.4K68 |
| 2025 | Gabe Ellwein | $180.7K | $200.9K68 | |
| 2025 | Ryan Staats | 46 | $23.1K | $25.7K68 |
| 2024 | PresidentChief Executive Officer and Chief Financial Officer | $248.6K | $282.3K68 | |
| 2024 | Former Chief Financial Officer | $158.7K | $169.2K68 | |
| 2024 | Former ChiefExecutive and Financial Officer | $66.5K | $112.2K68 |
SEC filer profile
How DYNATRONICS CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARDYNATRONICS CORP1
- CIK0000720875
- Employer ID (EIN)87-03984344
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inUtah4
- Fiscal year endsJune 301
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address7030 Park Centre Drive, Bldg D, Salt Lake City, UT 841211
- Mailing address7030 Park Center Dr, Salt Lake City, UT 841211
- Phone80156870001
- Shares outstanding16,048,734 as of Nov 12, 202512
- Public float$600.0K as of Dec 31, 20244
- AuditorTanner LLC, Salt Lake City, Utah PCAOB ID 270; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceMay 18, 19951
- Filings907 in all: 4 (382), 8-K (182), 10-Q (57), 10QSB (35), DEF 14A (31), 3 (30), 10-K (18), 4/A (17)1
All 42 form types
10KSB (12), ARS (10), 5 (9), UPLOAD (9), CORRESP (8), SC 13G/A (8), EFFECT (7), PRE 14A (7), S-3 (7), S-3/A (7), SC 13D/A (7), SC 13G (7), 10-K/A (6), 10-Q/A (6), REGDEX (6), D (5), S-8 (5), 8-K/A (4), 424B5 (3), DEFA14A (3), SC 13D (3), 10KSB/A (2), D/A (2), NT 10-Q (2), 10-K405 (1), 25-NSE (1), 5/A (1), DEFR14A (1), NT 10-K (1), PREM14A (1), PRER14A (1), S-8 POS (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)
- Latest filingsAnnual report (10-K) Oct 14, 2025
Quarterly report (10-Q) Nov 19, 2025
Proxy statement (DEF 14A) Oct 28, 2025
Latest 8-K (8-K) Jan 12, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock |
From the cover page of the 10-K filed Oct 14, 2025 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks DYNATRONICS CORP names in Item 1A of its 10-K filed Oct 14, 2025: 39 risks under these headings, as written.4
- Substantial Doubt About Our Ability to Continue as a Going Concern
- Risks Related to Our Business and Industry
- We expect to rely on third-party manufacturers and will be dependent on their quality and effectiveness.
- Disruption of our supply chain could have an adverse impact on our business, financial condition, and results of operations.
- Inflation and price fluctuations of raw materials, energy and other inputs could adversely affect our business.
- We are currently operating in a period of economic uncertainty, which has been significantly impacted by geopolitical instability due to the ongoing conflicts in Ukraine and in the Middle East and heightened tensions resulting from recent attacks on shipping vessels in the Red Sea.
- Any current or future outbreak of a health epidemic or other adverse public health developments could disrupt our manufacturing and supply chain, and adversely affect our business and operating results.
- We have a history of losses, and we may not sustain profitability in the future.
- We have incurred and may in the future incur non-cash impairment charges.
- We may need additional funding and may be unable to raise additional capital when needed, which could adversely affect our results of operations and financial condition.
- Our inability to successfully manage growth through acquisitions, and the integration of acquired businesses, products or technologies may present significant challenges and could harm our operating results.
- If we fail to establish new sales and distribution relationships or maintain our existing relationships, or if our third party distributors and dealers fail to commit sufficient time and effort or are otherwise ineffective in selling our products, our results of operations and future growth could be adversely impacted.
The other 28 risks
- Our products are regulated by numerous government agencies, both inside and outside the United States.
- Changing market patterns may affect demand for our products.
- The cost of healthcare has risen significantly over the past decade and numerous initiatives and reforms initiated by legislators, regulators and third-party payers to curb these costs have resulted in a consolidation trend in the restorative products industry as well as among our customers, including healthcare providers.
- The sale, marketing, and pricing of our products, and relationships with healthcare providers are under increased scrutiny by federal, state, and foreign government agencies.
- Our commercial activities internationally are subject to special risks associated with doing business in environments and jurisdictions that present a heightened corruption and trade sanctions risk.
- If we fail to obtain regulatory approval in foreign jurisdictions, then we cannot market our products in those jurisdictions.
- We store, process, and use data, some of which contain personal information and are subject to complex and evolving laws and regulations regarding privacy, data protection and other matters, which are subject to change.
- Market access could be a limiting factor in our growth.
- A significant percentage of our workforce is subject to a collective bargaining agreement.
- We rely on a combination of patents, trade secrets, and nondisclosure and non-competition agreements to protect our proprietary intellectual property, and we will continue to do so.
- Certain of the products we sell are subject to market and technological obsolescence.
- We may be adversely affected by product liability claims, unfavorable court decisions or legal settlements.
- Intellectual property litigation and infringement claims could cause us to incur significant expenses or prevent us from selling certain of our products.
- Covenants in our loan documents may restrict our business and operations and if we cannot satisfy our covenants, our financial condition and results of operations could be adversely affected.
- We operate in a highly competitive market segment, face competition from large, well-established medical device companies with significant resources, and may not be able to compete effectively.
- We are dependent on our senior management team, sales and marketing team, engineering team and other qualified personnel, and the loss of any of them could harm our business.
- Failures in, material damage to, or interruptions in our information technology systems, software or websites, including as a result of cyber-attacks, and difficulties in updating our existing software or developing or implementing new software, could have a material adverse effect on our business or results of operations.
- Risks Related to Our Common Stock
- A decline in the price of our common stock could affect our ability to raise working capital and adversely impact our operations.
- Our stock price has been volatile and we expect that it will continue to be volatile.
- Investors in our securities may experience substantial dilution upon the conversion of preferred stock to common, exercise of stock options and warrants, future issuances of stock, grants of restricted stock and the issuance of stock in connection with acquisitions of other companies.
- The stock markets (including the OTC Venture Market, on which our common stock is traded) have experienced significant price and volume fluctuations.
- We are able to issue shares of preferred stock with greater rights and preferences than our common stock.
- The concentration or potential concentration of equity ownership by Prettybrook Partners, LLC and its affiliates may limit your ability to influence corporate matters.
- Sales of a large number of our securities, or the perception that such sales might occur, could depress the market price of our common stock.
- Our ability to issue preferred stock could delay or prevent takeover attempts.
- As of the open of business on July 9, 2024, our common stock ceased trading on the NASDAQ Capital Market and began trading on the OTCQB Venture Market (the "OTCQB").
- In addition to the foregoing, the application of the "penny stock" rules could adversely affect the market price of our common stock and increase the transaction costs to sell those shares.
- We may pursue certain strategies that result in the deregistration of our common stock under the Exchange Act, which could negatively affect the liquidity and trading prices of our common stock and would result in less disclosure about the Company.
Legal proceedings
There are no pending legal proceedings of a material nature to which we are a party or to which any of our property is the subject.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24SEC EDGARCynthia L. McHenry, VP, Operations
- 25
- 26SEC EDGARJames Norman Ogilvie, Vice President
- 27SEC EDGARThomas J. Gephart, Sr. VP of Sales
- 28
- 29
- 30SEC EDGARLarry K. Beardall, Executive VP
- 31
- 32SEC EDGARRonald J. Hatch, VP R&D
- 33SEC EDGARAndrew Hulett, Board member
- 34SEC EDGARJohn Anthony Krier, Board member
- 35SEC EDGARScott Klosterman, Board member
- 36SEC EDGARRichard James Linder, Board member
- 37SEC EDGARBrian Larkin, Board member
- 38SEC EDGARDavid B. Holtz, Board member
- 39SEC EDGARR. Scott Ward, Board member
- 40
- 41SEC EDGARMark Crockett, Board member
- 42SEC EDGARE. Keith Hansen, Board member
- 43SEC EDGARHoward L. Edwards, Board member
- 44SEC EDGARJoseph H. Barton, Board member
- 45SEC EDGARVal John Christensen, Board member
- 46
- 47
- 48SEC EDGARShareholder vote
- 49SEC EDGARExecutive or director change
- 50SEC EDGARExecutive or director change
- 51SEC EDGAREntered a material agreement
- 52SEC EDGARShareholder vote
- 53SEC EDGARExecutive or director change
- 54
- 55SEC EDGARResults of operations
- 56SEC EDGARListing notice or transfer
- 57SEC EDGARExecutive or director change
- 58SEC EDGARResults of operations
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68